Huiyu Pharmaceutical (688553.SH): Obtained drug registration certificate relying on Bojing injection.

Zhtng Cijng APP News, Huy Zhyo (688553.SH) announced that the company has recently received the "Drug Registration Certificate" for the company's product Etoposide Injection issued by the National Medical Products Administration. Etoposide Injection is mainly indicated for small cell lung cancer, malignant lymphoma, malignant germ cell tumors, leukemia, neuroblastoma, rhabdomyosarcoma, ovarian cancer, non-small cell lung cancer, gastric cancer, and esophageal cancer.